메뉴 건너뛰기




Volumn 151, Issue 5, 2010, Pages 469-476

The impact of elective knee/hip replacement surgery and thromboprophylaxis with rivaroxaban or dalteparin on thrombin generation

Author keywords

Dalteparin; Hip knee replacement surgery; In vivo ex vivo thrombin generation; Rivaroxaban

Indexed keywords

ANTITHROMBIN; BLOOD CLOTTING FACTOR 10A INHIBITOR; D DIMER; DALTEPARIN; PROTHROMBIN; RIVAROXABAN; THROMBIN ANTITHROMBIN COMPLEX;

EID: 78349241402     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2010.08433.x     Document Type: Article
Times cited : (28)

References (36)
  • 2
    • 0028039182 scopus 로고
    • The effect of subcutaneous injection of unfractionated and low molecular weight heparin on thrombin generation in platelet rich plasma--a study in human volunteers
    • Bendetowicz, A.V., Kai, H., Knebel, R., Caplain, H., Hemker, H.C., Lindhout, T. & Beguin, S. (1994) The effect of subcutaneous injection of unfractionated and low molecular weight heparin on thrombin generation in platelet rich plasma--a study in human volunteers. Thrombosis and Haemostasis, 72, 705-712.
    • (1994) Thrombosis and Haemostasis , vol.72 , pp. 705-712
    • Bendetowicz, A.V.1    Kai, H.2    Knebel, R.3    Caplain, H.4    Hemker, H.C.5    Lindhout, T.6    Beguin, S.7
  • 3
    • 0038777381 scopus 로고    scopus 로고
    • Thrombin generation assessed as endogenous thrombin potential in patients with hyper- or hypo-coagulability
    • Chantarangkul, V., Clerici, M., Bressi, C., Giesen, P.L. & Tripodi, A. (2003) Thrombin generation assessed as endogenous thrombin potential in patients with hyper- or hypo-coagulability. Haematologica, 88, 547-554.
    • (2003) Haematologica , vol.88 , pp. 547-554
    • Chantarangkul, V.1    Clerici, M.2    Bressi, C.3    Giesen, P.L.4    Tripodi, A.5
  • 5
    • 13244253700 scopus 로고    scopus 로고
    • Thrombin generation for the control of heparin treatment, comparison with the activated partial thromboplastin time
    • Al Dieri, R., Alban, S., Beguin, S. & Hemker, H.C. (2004) Thrombin generation for the control of heparin treatment, comparison with the activated partial thromboplastin time. Journal of Thrombosis and Haemostasis, 2, 1395-1401.
    • (2004) Journal of Thrombosis and Haemostasis , vol.2 , pp. 1395-1401
    • Al Dieri, R.1    Alban, S.2    Beguin, S.3    Hemker, H.C.4
  • 6
    • 33644848865 scopus 로고    scopus 로고
    • Fixed dosage of low-molecular-weight heparins causes large individual variation in coagulability, only partly correlated to body weight
    • Al Dieri, R., Alban, S., Beguin, S. & Hemker, H.C. (2006) Fixed dosage of low-molecular-weight heparins causes large individual variation in coagulability, only partly correlated to body weight. Journal of Thrombosis and Haemostasis, 4, 83-89.
    • (2006) Journal of Thrombosis and Haemostasis , vol.4 , pp. 83-89
    • Al Dieri, R.1    Alban, S.2    Beguin, S.3    Hemker, H.C.4
  • 8
    • 46049090201 scopus 로고    scopus 로고
    • Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
    • Geerts, W.H., Bergqvist, D., Pineo, G.F., Heit, J.A., Samama, C.M., Lassen, M.R. & Colwell, C.W. (2008) Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest, 133, 381S-453S.
    • (2008) Chest , vol.133
    • Geerts, W.H.1    Bergqvist, D.2    Pineo, G.F.3    Heit, J.A.4    Samama, C.M.5    Lassen, M.R.6    Colwell, C.W.7
  • 9
    • 34247869897 scopus 로고    scopus 로고
    • Effect of the anti-factor Xa and anti-factor IIa activities of low-molecular-weight heparins upon the phases of thrombin generation
    • Gerotziafas, G.T., Petropoulou, A.D., Verdy, E., Samama, M.M. & Elalamy, I. (2007a) Effect of the anti-factor Xa and anti-factor IIa activities of low-molecular-weight heparins upon the phases of thrombin generation. Journal of Thrombosis and Haemostasis, 5, 955-962.
    • (2007) Journal of Thrombosis and Haemostasis , vol.5 , pp. 955-962
    • Gerotziafas, G.T.1    Petropoulou, A.D.2    Verdy, E.3    Samama, M.M.4    Elalamy, I.5
  • 10
    • 34147147085 scopus 로고    scopus 로고
    • In vitro inhibition of thrombin generation, after tissue factor pathway activation, by the oral, direct factor Xa inhibitor rivaroxaban
    • Gerotziafas, G.T., Elalamy, I., Depasse, F., Perzborn, E. & Samama, M.M. (2007b) In vitro inhibition of thrombin generation, after tissue factor pathway activation, by the oral, direct factor Xa inhibitor rivaroxaban. Journal of Thrombosis and Haemostasis, 5, 886-888.
    • (2007) Journal of Thrombosis and Haemostasis , vol.5 , pp. 886-888
    • Gerotziafas, G.T.1    Elalamy, I.2    Depasse, F.3    Perzborn, E.4    Samama, M.M.5
  • 11
    • 35448932027 scopus 로고    scopus 로고
    • Effects of the oral, direct factor xa inhibitor rivaroxaban on platelet-induced thrombin generation and prothrombinase activity
    • Graff, J., Von, H.N., Misselwitz, F., Kubitza, D., Becka, M., Breddin, H.K. & Harder, S. (2007) Effects of the oral, direct factor xa inhibitor rivaroxaban on platelet-induced thrombin generation and prothrombinase activity. Journal of Clinical Pharmacology, 47, 1398-1407.
    • (2007) Journal of Clinical Pharmacology , vol.47 , pp. 1398-1407
    • Graff, J.1    Von, H.N.2    Misselwitz, F.3    Kubitza, D.4    Becka, M.5    Breddin, H.K.6    Harder, S.7
  • 12
    • 0036145979 scopus 로고    scopus 로고
    • Limitations of the laboratory monitoring of heparin therapy. Scientific and Standardization Committee Communications: on behalf of the Control of Anticoagulation Subcommittee of the Scientific and Standardization Committee of the International Society of Thrombosis and Haemostasis
    • Greaves, M. (2002) Limitations of the laboratory monitoring of heparin therapy. Scientific and Standardization Committee Communications: on behalf of the Control of Anticoagulation Subcommittee of the Scientific and Standardization Committee of the International Society of Thrombosis and Haemostasis. Thrombosis and Haemostasis, 87, 163-164.
    • (2002) Thrombosis and Haemostasis , vol.87 , pp. 163-164
    • Greaves, M.1
  • 15
    • 33751210094 scopus 로고    scopus 로고
    • Thrombin generation, a function test of the haemostatic-thrombotic system
    • Hemker, H.C., Al Dieri, R., De Smedt, E. & Beguin, S. (2006) Thrombin generation, a function test of the haemostatic-thrombotic system. Thrombosis and Haemostasis, 96, 553-561.
    • (2006) Thrombosis and Haemostasis , vol.96 , pp. 553-561
    • Hemker, H.C.1    Al Dieri, R.2    De Smedt, E.3    Beguin, S.4
  • 16
    • 45949086068 scopus 로고    scopus 로고
    • Parenteral anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
    • Hirsh, J., Bauer, K.A., Donati, M.B., Gould, M., Samama, M.M. & Weitz, J.I. (2008) Parenteral anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest, 133, 141S-159S.
    • (2008) Chest , vol.133
    • Hirsh, J.1    Bauer, K.A.2    Donati, M.B.3    Gould, M.4    Samama, M.M.5    Weitz, J.I.6
  • 17
    • 0029040795 scopus 로고
    • The role of tissue factor pathway inhibitor in the mediation of the antithrombotic actions of heparin and low-molecular-weight heparin
    • Hoppensteadt, D.A., Jeske, W., Fareed, J. & Bermes, Jr, E.W. (1995) The role of tissue factor pathway inhibitor in the mediation of the antithrombotic actions of heparin and low-molecular-weight heparin. Blood Coagulation & Fibrinolysis, 6(Suppl 1), S57-S64.
    • (1995) Blood Coagulation & Fibrinolysis , vol.6 , Issue.SUPPL. 1
    • Hoppensteadt, D.A.1    Jeske, W.2    Fareed, J.3    Bermes Jr, E.W.4
  • 18
    • 46049106502 scopus 로고    scopus 로고
    • Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial
    • Kakkar, A.K., Brenner, B., Dahl, O.E., Eriksson, B.I., Mouret, P., Muntz, J., Soglian, A.G., Pap, A.F., Misselwitz, F. & Haas, S. (2008) Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial. Lancet, 372, 31-39.
    • (2008) Lancet , vol.372 , pp. 31-39
    • Kakkar, A.K.1    Brenner, B.2    Dahl, O.E.3    Eriksson, B.I.4    Mouret, P.5    Muntz, J.6    Soglian, A.G.7    Pap, A.F.8    Misselwitz, F.9    Haas, S.10
  • 19
    • 29144518504 scopus 로고    scopus 로고
    • Safety, pharmacodynamics, and pharmacokinetics of BAY 59-7939--an oral, direct Factor Xa inhibitor--after multiple dosing in healthy male subjects
    • Kubitza, D., Becka, M., Wensing, G., Voith, B. & Zuehlsdorf, M. (2005) Safety, pharmacodynamics, and pharmacokinetics of BAY 59-7939--an oral, direct Factor Xa inhibitor--after multiple dosing in healthy male subjects. European Journal of Clinical Pharmacology, 61, 873-880.
    • (2005) European Journal of Clinical Pharmacology , vol.61 , pp. 873-880
    • Kubitza, D.1    Becka, M.2    Wensing, G.3    Voith, B.4    Zuehlsdorf, M.5
  • 22
    • 0027399508 scopus 로고
    • Factor Xa inhibition: correlation between the plasma levels of anti-Xa activity and occurrence of thrombosis and haemorrhage
    • Leizorovicz, A., Bara, L., Samama, M.M. & Haugh, M.C. (1993) Factor Xa inhibition: correlation between the plasma levels of anti-Xa activity and occurrence of thrombosis and haemorrhage. Haemostasis, 23(Suppl 1), 89-98.
    • (1993) Haemostasis , vol.23 , Issue.SUPPL. 1 , pp. 89-98
    • Leizorovicz, A.1    Bara, L.2    Samama, M.M.3    Haugh, M.C.4
  • 23
    • 13244264708 scopus 로고    scopus 로고
    • Clinical measurement of thrombin generation by calibrated automated thrombography requires contact factor inhibition
    • Luddington, R. & Baglin, T. (2004) Clinical measurement of thrombin generation by calibrated automated thrombography requires contact factor inhibition. Journal of Thrombosis and Haemostasis, 2, 1954-1959.
    • (2004) Journal of Thrombosis and Haemostasis , vol.2 , pp. 1954-1959
    • Luddington, R.1    Baglin, T.2
  • 25
    • 78349293958 scopus 로고    scopus 로고
    • NICE. Venous thromboembolism: reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital. Clinical guidance 92.
    • NICE. (2010) Venous thromboembolism: reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital. Clinical guidance 92.
    • (2010)
  • 28
    • 0030603839 scopus 로고    scopus 로고
    • Risk of deep-venous thrombosis after hospital discharge in patients having undergone total hip replacement: double-blind randomised comparison of enoxaparin versus placebo
    • Planes, A., Vochelle, N., Darmon, J.Y., Fagola, M., Bellaud, M. & Huet, Y. (1996) Risk of deep-venous thrombosis after hospital discharge in patients having undergone total hip replacement: double-blind randomised comparison of enoxaparin versus placebo. Lancet, 348, 224-228.
    • (1996) Lancet , vol.348 , pp. 224-228
    • Planes, A.1    Vochelle, N.2    Darmon, J.Y.3    Fagola, M.4    Bellaud, M.5    Huet, Y.6
  • 30
    • 0023884505 scopus 로고
    • Deep venous thrombosis: a continuing problem
    • Scurr, J.H., Coleridge-Smith, P.D. & Hasty, J.H. (1988) Deep venous thrombosis: a continuing problem. BMJ, 297, 28.
    • (1988) BMJ , vol.297 , pp. 28
    • Scurr, J.H.1    Coleridge-Smith, P.D.2    Hasty, J.H.3
  • 32
    • 0029028086 scopus 로고
    • Changes in circulatory indices of thrombosis and fibrinolysis during total knee arthroplasty performed under tourniquet
    • Sharrock, N.E., Go, G., Sculco, T.P., Ranawat, C.S., Maynard, M.J. & Harpel, P.C. (1995b) Changes in circulatory indices of thrombosis and fibrinolysis during total knee arthroplasty performed under tourniquet. The Journal of Arthroplasty, 10, 523-528.
    • (1995) The Journal of Arthroplasty , vol.10 , pp. 523-528
    • Sharrock, N.E.1    Go, G.2    Sculco, T.P.3    Ranawat, C.S.4    Maynard, M.J.5    Harpel, P.C.6
  • 34
    • 41849145377 scopus 로고    scopus 로고
    • Corn trypsin inhibitor in fluorogenic thrombin-generation measurements is only necessary at low tissue factor concentrations and influences the relationship between factor VIII coagulant activity and thrombogram parameters
    • Van Veen, J.J., Gatt, A., Cooper, P.C., Kitchen, S., Bowyer, A.E. & Makris, M. (2008) Corn trypsin inhibitor in fluorogenic thrombin-generation measurements is only necessary at low tissue factor concentrations and influences the relationship between factor VIII coagulant activity and thrombogram parameters. Blood Coagulation & Fibrinolysis, 19, 183-189.
    • (2008) Blood Coagulation & Fibrinolysis , vol.19 , pp. 183-189
    • Van Veen, J.J.1    Gatt, A.2    Cooper, P.C.3    Kitchen, S.4    Bowyer, A.E.5    Makris, M.6
  • 35
    • 66449099711 scopus 로고    scopus 로고
    • Metabolism and excretion of rivaroxaban, an oral, direct factor Xa inhibitor, in rats, dogs, and humans
    • Weinz, C., Schwarz, T., Kubitza, D., Mueck, W. & Lang, D. (2009) Metabolism and excretion of rivaroxaban, an oral, direct factor Xa inhibitor, in rats, dogs, and humans. Drug Metabolism and Disposition, 37, 1056-1064.
    • (2009) Drug Metabolism and Disposition , vol.37 , pp. 1056-1064
    • Weinz, C.1    Schwarz, T.2    Kubitza, D.3    Mueck, W.4    Lang, D.5
  • 36
    • 0037394009 scopus 로고    scopus 로고
    • Low-molecular-weight heparins: are they all the same?
    • White, R.H. & Ginsberg, J.S. (2003) Low-molecular-weight heparins: are they all the same? British Journal of Haematology, 121, 12-20.
    • (2003) British Journal of Haematology , vol.121 , pp. 12-20
    • White, R.H.1    Ginsberg, J.S.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.